Bharat Biotech forays into cell and gene therapy with $75 million vertically integrated CGT, viral production facility at Genome Valley

Bharat Biotech forays into cell and gene therapy with $75 million vertically integrated CGT, viral production facility at Genome Valley

Bharat Biotech forays into cell and gene therapy with $75 million vertically integrated CGT, viral production facility at Genome Valley
Bharat Biotech forays into cell and gene therapy with $75 million vertically integrated CGT, viral production facility at Genome Valley